http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015505566-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 |
| filingDate | 2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015505566-A |
| titleOfInvention | Ribonucleotide reductase inhibitors and methods of use |
| abstract | Described herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of RRM1 / RRM2 holoenzyme, and methods for synthesizing these novel compounds. The compounds can be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as certain cancer types, mitochondrial diseases, or degenerative diseases. |
| priorityDate | 2012-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 272.